Prodotto aggiunto correttamente al carrello.

discount label
H-STPESANL-OH
Visualizzare in 3D

Biosynth logo

H-STPESANL-OH

Rif. 3D-PP44299

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Consegna stimata in Stati Uniti, il Venerdì 27 Dicembre 2024

Informazioni sul prodotto

Nome:
H-STPESANL-OH
Sinonimi:
  • NH2-Ser-Thr-Pro-Glu-Ser-Ala-Asn-Leu-OH
Descrizione:

Peptide H-STPESANL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-STPESANL-OH include the following: IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of YM Mueller , DH Do, SR Altork , CM Artlett - The Journal of , 2008 - journals.aai.orghttps://journals.aai.org/jimmunol/article/180/1/350/78382 Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia TM Allen , DH O'Connor , P Jing, JL Dzuris, BR Mothe - Nature, 2000 - nature.comhttps://www.nature.com/articles/35030124 Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design? T De Oliveira , M Salemi , M Gordon , AM Vandamme - Genetics, 2004 - academic.oup.comhttps://academic.oup.com/genetics/article-abstract/167/3/1047/6050617 Maintenance or Emergence of Chronic Phase Secondary Cytotoxic T Lymphocyte Responses after Loss of Acute Phase Immunodominant Responses Does Not MS Keckler, VL Hodara , LM Parodi - BioMed Research , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2010/279391 The Antiviral Efficacy of Simian Immunodeficiency Virus-Specific CD8+ T Cells Is Unrelated to Epitope Specificity and Is Abrogated by Viral Escape JT Loffredo, BJ Burwitz , EG Rakasz - Journal of , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01912-06 Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central Africa JP Nkolola, EGT Wee, EJ Im, CP Jewell, N Chen - Gene therapy, 2004 - nature.comhttps://www.nature.com/articles/3302241 Analysis of the immune response and viral evolution during the acute phase of SIV infection H Horton, T Vogel, D O'Connor , L Picker , DI Watkins - Vaccine, 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X02000695 Induction of long-lasting multi-specific CD8+ T cells by a four-component DNA-MVA/HIVA-RENTA candidate HIV-1 vaccine in rhesus macaques EJ Im, JP Nkolola, K di Gleria - European journal of , 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200636482 Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely E Connick , JM Folkvord, KT Lind - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/193/11/5613/96601 Compartmentalization of SIV Replication Within Secondary Lymphoid Tissues of Rhesus Macaques is Linked to Disease Stage and Inversely Related to E Connick , JM Folkvord, KT Lind - (Baltimore, Md.: 1950 , 2014 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239212/ Vaccination with CTL epitopes that escape: an alternative approach to HIV vaccine development? D O'Connor , T Allen , DI Watkins - Immunology letters, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165247801002681 Simultaneous Positive and Purifying Selection on Overlapping Reading Frames of the tat andvpr Genes of Simian Immunodeficiency Virus AL Hughes, K Westover, J da Silva - Journal of , 2001 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.75.17.7966-7972.2001 Location and dynamics of the immunodominant CD8 T cell response to SIVΔnef immunization and SIVmac251 vaginal challenge AK Sasikala-Appukuttan, HO Kim, NJ Kinzel, JJ Hong - PloS one, 2013 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0081623 The Mucosal Barrier and Anti-Viral Immune Responses can Eliminate Portions of the Viral Population during Transmission and Early Viral Growth AE Golfinos, DD Gellerup, H Schweigert - 2021 - preprints.orghttps://www.preprints.org/manuscript/202105.0206

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP44299 H-STPESANL-OH

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".